{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-22-119584","form_type":"8-K","ticker":"JAGX","cik":"0001585608","company_name":"Jaguar Health, Inc.","filed_at":"2022-11-16T23:59:59+00:00","discovered_at":"2026-05-14T18:03:51.288878+00:00","generated_at":"2026-06-21T17:29:02.510678+00:00","sec_items":["1.01","5.03","3.02","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Jaguar Health issues Series F Preferred to SynWorld with 6B votes per share to facilitate reverse stock split","bullets":["Issued 10 shares of Series F Preferred to SynWorld Technologies for $100 total ($10/share).","Series F Preferred carries 6 billion votes per share, exercisable only on a proposed reverse stock split.","Reverse split ratio range: 1-for-3 to 1-for-75; board to set exact ratio before Jan 22, 2024.","Preferred shares mandate redemption within 3 business days after stockholder vote on reverse split.","Company will call a special meeting for stockholder approval of the reverse stock split amendment."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-22-119584","json":"https://secwatch.observer/filing/0001104659-22-119584.json","markdown":"https://secwatch.observer/filing/0001104659-22-119584.md","text":"https://secwatch.observer/filing/0001104659-22-119584.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1585608/000110465922119584/0001104659-22-119584-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1585608/000110465922119584/tm2229955d2_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-21T17:29:02.510678+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"181eccaa6d546219a6e334d96740f074230b6e46","claim":"Jaguar Health, Inc.: Filed Certificate of Designation for Series F Preferred Stock, establishing the preferences, rights, and limitations of the new series (effective 2022-11-10).","evidence_excerpt":"The terms of the Series F Preferred Stock are set forth in a Certificate of Designation of Preferences, Rights and Limitations of Series F Preferred Stock (the “Certificate of Designation”) filed with the Secretary of State of Delaware (the “DE SOS”) and effective on November 10, 2022.","evidence_source":"SEC 8-K Item 5.03/5.05/5.06","evidence_url":"https://www.sec.gov/Archives/edgar/data/1585608/000110465922119584/0001104659-22-119584-index.htm","confidence":0.9,"family_label":"Governance Changes","details":[{"label":"Change","value":"charter amendment"},{"label":"Effective","value":"2022-11-10"}],"fact_type":"governance_change"},{"claim_id":"fdbaa934bffbd092433989e4d31f7a179e3119ed","claim":"Jaguar Health, Inc. entered into Securities Purchase Agreement with SynWorld Technologies Corporation valued at $100 (effective 2022-11-11).","evidence_excerpt":"On November 11, 2022, Jaguar Health, Inc. (the “Company”) entered into a Securities Purchase Agreement (the “Purchase Agreement”) with SynWorld Technologies Corporation (“SynWorld”), pursuant to which the Company agreed to issue, in a private placement (the “Preferred Issuance Transaction”), an aggregate of ten shares (the “Series F Preferred Shares”) of the Company’s Series F Preferred Stock, par value $0.0001 per share (“Series F Preferred Stock”), at a price per share equal to the Series F Original Issue Price (as defined below) for gross proceeds of $100.","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1585608/000110465922119584/0001104659-22-119584-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"equity purchase"},{"label":"Counterparty","value":"SynWorld Technologies Corporation"},{"label":"Value","value":"$100"},{"label":"Effective","value":"2022-11-11"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}